Colfax Corporation – NYSE:CFX

Add to watchlist

$39.06

Market closed

Open in about 2 hours

+6.29%

month

-14.12%

quarter

-10.02%

year

Market Cap	2.12B
Enterprise value	3.69B

P/E	28.55
EV/Sales	0.92
EV/EBITDA	7.80
Price/Sales	0.52
Price/Book	0.45
PEG ratio	0.55
EPS	-1.49

Revenue	1.81B
EBITDA	129.57M
Income	-81.90M
Revenue Q/Q	27.11%
Revenue Y/Y	14.02%

Profit margin	1.69%
Oper. margin	6.41%
Gross margin	41.84%
EBIT margin	6.41%
EBITDA margin	7.13%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Colfax Corporation (NYSE:CFX): Profit margin
Jun 2023	428.50M	-9.99M	-2.33%
Sep 2023	417.52M	-2.88M	-0.69%
Dec 2023	455.02M	2.96M	0.65%
Mar 2024	516.26M	-71.99M	-13.95%

Colfax Corporation (NYSE:CFX): Earnings per share (EPS)
2021-02-18	0.5	0.51
2021-04-29	0.4	0.44
2021-07-28	0.53	0.56
2021-11-04	0.54	0.54

Colfax Corporation (NYSE:CFX): Debt to assets
Jun 2023	4443553000	992.79M	22.34%
Sep 2023	4400917000	959.18M	21.8%
Dec 2023	4509334000	1.08B	24.14%
Mar 2024	5478681000	2.16B	39.57%

Colfax Corporation (NYSE:CFX): Cash Flow
Jun 2023	28.10M	-131.60M	114.21M
Sep 2023	31.01M	-17.10M	-13.70M
Dec 2023	68.41M	-59.37M	2.78M
Mar 2024	-36.15M	-797.84M	864.54M

Colfax alternative data

Colfax
Employees

Colfax Corporation (NYSE:CFX): Employee count
Aug 2023	16,200
Sep 2023	16,200
Oct 2023	16,200
Nov 2023	16,200
Dec 2023	16,200
Jan 2024	16,200
Feb 2024	16,200
Mar 2024	16,200
Apr 2024	16,200
May 2024	16,200
Jun 2024	16,200
Jul 2024	16,200

Colfax Corporation (NYSE:CFX): Insider trades (number of shares)
Period	Buy	Sel
May 2021	0	224677
Jul 2021	0	150000
Aug 2021	250200	302892
Sep 2021	0	121339
Oct 2021	0	89862
Nov 2021	0	80801
Dec 2021	0	6711
Feb 2022	0	222655
Mar 2022	0	26979

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	7 Mar 2022	PRYOR DANIEL A officer: EVP, Str..	Common stock, par value $.001	3,463	$38.88	$134,641
Sale	7 Mar 2022	PRYOR DANIEL A officer: EVP, Str..	Common stock, par value $.001	3,463	$38.88	$134,641
Sale	7 Mar 2022	PRYOR DANIEL A officer: EVP, Str..	Common stock, par value $.001	3,463	$38.88	$134,641
Sale	7 Mar 2022	KAMBEYANDA SHYAM officer: ESAB Pre..	Common stock, par value $.001	2,788	$38.88	$108,397
Sale	7 Mar 2022	KAMBEYANDA SHYAM officer: ESAB Pre..	Common stock, par value $.001	2,788	$38.88	$108,397
Sale	7 Mar 2022	KAMBEYANDA SHYAM officer: ESAB Pre..	Common stock, par value $.001	2,788	$38.88	$108,397
Sale	7 Mar 2022	LANG PATRICIA A officer: SVP, Chief HR Officer officer: SVP, Chief HR Officer	Common stock, par value $.001	1,425	$38.88	$55,404
Sale	7 Mar 2022	TANDY BRADLEY J officer: SVP, Gen..	Common stock, par value $.001	1,498	$38.88	$58,242
Sale	7 Mar 2022	TREROTOLA MATTHEW L. director, officer..	Common stock, par value $.001	12,002	$38.88	$466,638
Sale	7 Mar 2022	TREROTOLA MATTHEW L. director, officer..	Common stock, par value $.001	12,002	$38.88	$466,638

Colfax
Earnings Call Transcripts

Quarter	Transcript
Q4 2021 22 Feb 2022	Q4 2021 Earnings Call Transcript
Q3 2021 7 Nov 2021	Q3 2021 Earnings Call Transcript
Q2 2021 30 Jul 2021	Q2 2021 Earnings Call Transcript
Q1 2021 1 May 2021	Q1 2021 Earnings Call Transcript

CFX earnings call transcripts

Colfax
Executives

Insider	Age	Compensation
Mr. Matthew L. Trerotola (1967) Pres, Chief Executive Officer & Director	58	$2,410,000
Mr. Brady R. Shirley (1966) Chief Executive Officer of DJO & Executive Vice President	59	$1,440,000
Mr. Shyam Kambeyanda (1971) Executive Vice President and Chief Executive Officer & Pres of ESAB	54	$1,110,000
Mr. Christopher M. Hix (1962) Executive Vice President of Fin. & Chief Financial Officer	63	$1,090,000
Mr. Daniel A. Pryor (1968) Executive Vice President of Strategy & Bus. Devel.	57	$959,000
Mr. Mitchell P. Rales (1957) Co-Founder & Chairman	68	$1

Colfax
Latest News

Wednesday, 2 October 2024
07:35	Natural Grocers® Announces the Closure of Downtown Denver Store at Colfax and Washington	prnewswire.com
Monday, 20 May 2024
01:03	Enovis (NYSE:ENOV) vs. Envoy Medical (NASDAQ:COCH) Financial Survey	https://www.defenseworld.net
Wednesday, 30 March 2022
20:21	ESAB Set to Join S&P MidCap 400; PROG Holdings to Join S&P SmallCap 600	prnewswire.com
Tuesday, 15 March 2022
15:15	KeyBanc, Morgan Stanley Slash Price Target On Colfax	Benzinga
Wednesday, 23 February 2022
10:48	Colfax (CFX) Q4 Earnings & Revenues Surpass Estimates, Up Y/Y	Zacks Investment Research
Tuesday, 22 February 2022
11:24	Colfax Corporation (CFX) CEO Matt Trerotola on Q4 2021 Results - Earnings Call Transcript	Seeking Alpha
08:29	Colfax (CFX) Beats Q4 Earnings and Revenue Estimates	Zacks Investment Research
Friday, 18 February 2022
12:25	Colfax (CFX) Exhibits Strong Prospects, Headwinds Persist	Zacks Investment Research
Thursday, 20 January 2022
17:00	Colfax Schedules Fourth Quarter and Fiscal Year 2021 Earnings Release and Conference Call	GlobeNewsWire
Monday, 17 January 2022
10:46	Colfax's (CFX) Product Strength Aids Amid Cost & Supply Woes	Zacks Investment Research
Monday, 10 January 2022
07:54	Colfax to Present at the 40th Annual JP Morgan Healthcare Conference	GlobeNewsWire
Sunday, 28 November 2021
22:12	Forget The Covid Apocalypse, Focus On Stocks That Closed Green After Friday's Monster Sell Off	Seeking Alpha
Sunday, 7 November 2021
10:10	Colfax Corporation's (CFX) CEO Matt Trerotola on Q3 2021 Results - Earnings Call Transcript	Seeking Alpha
Friday, 5 November 2021
13:44	Colfax (CFX) Meets Earnings Estimates in Q3, Lowers View	Zacks Investment Research
Thursday, 4 November 2021
09:11	Colfax (CFX) Q3 Earnings Match Estimates	Zacks Investment Research
08:03	Colfax Clocks 20% Sales Growth In Q3, Beats Estimates	Benzinga
Saturday, 30 October 2021
09:59	Starboard Value spots fresh opportunities for diversified tech company Colfax	CNBC
Thursday, 28 October 2021
16:49	Colfax (CFX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release	Zacks Investment Research
Monday, 18 October 2021
10:45	Colfax Schedules Third Quarter 2021 Earnings Release and Conference Call	GlobeNewsWire
Wednesday, 22 September 2021
07:00	DJO® Expands Active, Adaptive Healing Offerings with Introduction of MedShape® DynaNail Hybrid™	Business Wire
Tuesday, 31 August 2021
07:00	DJO® Introduces New EMPOWR Dual Mobility™ Hip System at AAOS	Business Wire
Friday, 27 August 2021
13:05	Colfax (CFX) Up 2.9% Since Last Earnings Report: Can It Continue?	Zacks Investment Research

Ideas & Opinions

Seeking Alpha 29 Nov 2021

Forget The Covid Apocalypse, Focus On Stocks That Closed Green After Friday's Monster Sell Off

Frequently Asked Questions (FAQ)

What's the price of Colfax stock today?

One share of Colfax stock can currently be purchased for approximately $39.06.
When is Colfax's next earnings date?

Unfortunately, Colfax's (CFX) next earnings date is currently unknown.
Does Colfax pay dividends?

No, Colfax does not pay dividends.
How much money does Colfax make?

Colfax has a market capitalization of 2.12B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9.22% to 1.71B US dollars. Colfax made a loss 33.26M US dollars in net income (profit) last year or $0.54 on an earnings per share basis.
What is Colfax's stock symbol?

Colfax Corporation is traded on the NYSE under the ticker symbol "CFX".
What is Colfax's primary industry?

Company operates in the Industrials sector and Industrial - Machinery industry.
How do i buy shares of Colfax?

Shares of Colfax can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Colfax's key executives?
Colfax's management team includes the following people:
- Mr. Matthew L. Trerotola Pres, Chief Executive Officer & Director(age: 58, pay: $2,410,000)
- Mr. Brady R. Shirley Chief Executive Officer of DJO & Executive Vice President(age: 59, pay: $1,440,000)
- Mr. Shyam Kambeyanda Executive Vice President and Chief Executive Officer & Pres of ESAB(age: 54, pay: $1,110,000)
- Mr. Christopher M. Hix Executive Vice President of Fin. & Chief Financial Officer(age: 63, pay: $1,090,000)
- Mr. Daniel A. Pryor Executive Vice President of Strategy & Bus. Devel.(age: 57, pay: $959,000)
- Mr. Mitchell P. Rales Co-Founder & Chairman(age: 68, pay: $1)
Is Colfax founder-led company?

Yes, Colfax is a company led by its founder Mr. Mitchell P. Rales.
How many employees does Colfax have?

As Jul 2024, Colfax employs 16,200 workers.
When Colfax went public?

Colfax Corporation is publicly traded company for more then 17 years since IPO on 8 May 2008.
What is Colfax's official website?

The official website for Colfax is colfaxcorp.com.
Where are Colfax's headquarters?

Colfax is headquartered at 420 National Business Pkwy Fl 5, Annapolis Junction, MARYLAND.
How can i contact Colfax?

Colfax's mailing address is 420 National Business Pkwy Fl 5, Annapolis Junction, MARYLAND and company can be reached via phone at +1 301 323 9000.

Colfax Corporation

colfaxcorp.com

Exchange:

NYSE

Full time employees:

16,200

Industry:

Industrial - Machinery

Sector:

Industrials

Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.

+1 301 323 9000

420 National Business Pkwy Fl 5
Annapolis Junction, MARYLAND 19808

CIK: 0001420800
ISIN: US1940141062
CUSIP: 194014106